Clinical Trials Browser

Phase 1/2 × OTHER × tivozanib × Clear all

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT01835223 2020-10-28

Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery

Phase 1/2 Completed

33 enrolled 15 charts

Gastrointestinal

Advanced Adult Hepatocellular Carcinoma

NCT01058655 2017-04-13

RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer

Phase 1/2 Completed

56 enrolled 15 charts

Gastrointestinal

Gastrointestinal Neoplasms, Colorectal Neoplasms

NCT01728181 2013-07-25

A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation

Phase 1/2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Disease

Clinical Trials

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery

RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer

A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation